Analysis of in vitro lymphocyte adhesion and transendothelial migration by fluorescent-beads-based flow cytometric cell counting

Cytometry

Volumn 32, Issue 1, 1998, Pages 37-43

  Molema, Grietje ^a,b   Mesander, Geert ^a   Kroesen, Bart Jan ^a   Helfrich, Wijnand ^a   Meijer, Dirk K F ^b   De Leij, Lou F M H ^a,b  

^a Utrecht Inst Drug Explor   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Adhesion; Flow cytometry; Fluorescent beads; In vitro quantitation; Lymphocyte; Transendothelial migration

Indexed keywords

ANTIGEN BINDING; ARTICLE; CELL ADHESION; CELL COUNT; CELL LABELING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE MIGRATION; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; ANTIGENS, NEOPLASM; CELL ADHESION; CELL ADHESION MOLECULES; CELL COUNT; CELL MOVEMENT; CELL SEPARATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICROSPHERES; PHENOTYPE; REPRODUCIBILITY OF RESULTS; UMBILICAL VEINS;

EID: 0031921880     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19980501)32:1<37::AID-CYTO5>3.0.CO;2-C     Document Type: Article

References (20)

1. Kroesen BJ, Helfrich W, Bakker A, Wubbena AS, Bakker H, Kal HB, The TH, de Leij L: Reduction of EGP-2 positive pulmonary metastases by bispecific-antibody-redirected T cells in an immunocompetent rat model. Int J Cancer 61:812-818, 1995.
2. Kroesen BJ, ter Haar A, Spakman H, Willemse P, Sleijfer DT, de Vries EGE, Mulder NH, Berendsen HH, Limburg PC, The TH, de Leij L: Local antitumour treatment in carcinoma patients with bispecific-monoclonal-antibody-redirected T cells. Cancer Immunol Immunother 37:400-407, 1993.
3. Kroesen BJ, Buter J, Sleijfer DT, Janssen RAJ, van der Graaf WTA, The TH, de Leij L, Mulder NH: Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2. Br J Cancer 70:652-661, 1994.
4. Roscoe RA, Rybka WB, Winkelstein A, Houston AM, Kiss JE: Enumeration of CD34 + hematopoietic stem cells for reconstitution following myeloablative therapy. Cytometry 16:74-79, 1994.
5. Rider JR, Moore G, Payrat JM, Chan D, Morse C, Standen GR, Pamphilon DH: Evaluation of a new, integral, whole blood filter (RS2000) system for prestorage leucodepletion of SAG-M red cells. Br J Haematol 94:184-190, 1996.
6. Oppenheimer-Marks N, Davis LS, Lipsky PE: Human T lymphocyte adhesion to endothelial cells and transendothelial migration. Alteration of receptor use relates to the activation status of both the T cell and the endothelial cell. J Immunol 145:140-148, 1990.
7. Issekutz TB: Effects of six different cytokines on lymphocyte adherence to microvascular endothelium and in vivo lymphocyte migration in the rat. J Immunol 144:2140-2146, 1990.
8. Thornhill MH, Wellicome SM, Mahiouz DL, Lanchbury JS, Kyan-Aung U, Haskard DO: Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and independent binding mechanisms. J Immunol 146:592-598, 1991.
9. Kitayama J, Nagawa H, Yasuhara H, Tsuno N, Kimura W, Shibata Y, Muto T: Suppressive effect of basic fibroblast growth factor on transendothelial emigration of CD4(+) T-lymphocyte. Cancer Res 54:4729-4733, 1994.
10. Fabry Z, Topham DJ, Fee D, Herlein J, Carlino JA, Hart MN, Sriram S: TGF-b2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo. J Immunol 155:325-332, 1995.
11. Roth SJ, Carr MW, Rose SS, Springer TA: Characterization of transendothelial chemotaxis of T lymphocytes. J Immunol Methods 188:97-116, 1995.
12. Van Kooyk Y, van de Wiel-van Kemenade E, Weder P, Huijbens RJ, Figdor CG: Lymphocyte function-associated antigen 1 dominates very late antigen 4 in binding of activated T cells to endothelium. J Exp Med 177:185-190, 1993.
13. Pryce G, Santos W, Male D: An assay for the analysis of lymphocyte migration across cerebral endothelium in vitro. J Immunol Methods 167:55-63, 1994.
14. Tolosa E, Shaw S: A fluorogenic assay of endogenous phosphatase for assessment of cell adhesion. J Immunol Methods 192:165-172, 1996.
15. de Leij L, Helfrich W, Stein R, Mattes MJ: SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2. Int J Cancer 8:60-63, 1994.
16. Mulder AB, Hegge Paping KS, Magielse CP, Blom NR, Smit JW, van der Meer J, Hallie MR, Bom VJ: Tumor necrosis factor alpha-induced endothelial tissue factor is located on the cell surface rather than in the subendothelial matrix. Blood 84:1559-1566, 1994.
17. Lidington E, Nohammer C, Dominguez M, Ferry B, Rose ML: Inhibition of the transendothelial migration of human lymphocytes but not monocytes by phosphodiesterase inhibitors. Clin Exp Immunol 104: 66-71, 1996.
18. Korlipara LV, Leon MP, Rix DA, Douglas MS, Gibbs P, Bassendine MF, Kirby JA: Development of a flow cytometric assay to quantify lymphocyte adhesion to cytokine-stimulated human endothelial and biliary epithelial cells. J Immunol Methods 191:121-130, 1996.
19. Campbell JJ, Qin S, Bacon KB, Mackay CR, Butcher EC: Biology of chemokine and classical chemoattractant receptors: Differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells. J Cell Biol 134:255-266, 1996.
20. Pankonin G, Reipert B, Ager A: Interactions between interleukin-2-activated lymphocytes and vascular endothelium: Binding to and migration across specialized and non-specialized endothelia. Immunology 77:51-60, 1992.